In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
One in two women with advanced ovarian cancer has an HRD-positive tumor
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
Lenalidomide is used to treat various types of cancers.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
Orelabrutinib is a highly selective BTK inhibitor developed by InnoCare for the treatment of cancers and autoimmune diseases.
Phase 2 study to assess efficacy and safety of once daily linperlisib in patients with advanced peripheral T/NK cell lymphoma
Subscribe To Our Newsletter & Stay Updated
